Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A2 | P23975 | 2/20 | 0.44 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.44 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.44 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.44 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.44 |
| ▸ | PPARG | P37231 | 1/20 | 0.41 |
| ▸ | PPARD | Q03181 | 1/20 | 0.41 |
| ▸ | PPARA | Q07869 | 1/20 | 0.41 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.36 |
| ▸ | IDO1 | P14902 | 1/20 | 0.34 |
| ▸ | TDO2 | P48775 | 1/20 | 0.34 |
| ▸ | HTR1A | P08908 | 3/20 | 0.33 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.33 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.33 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.33 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.33 |
| ▸ | CES2 | O00748 | 1/20 | 0.31 |
| ▸ | CES1 | P23141 | 1/20 | 0.31 |
| ▸ | LCK | P06239 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31556324 | 0.82 | CYP3A4 (0.44) | SLC6A2SLC6A4CYP3A4CYP2D6SLC6A3 | |
| SCHEMBL9665116 | 0.80 | CYP3A4 (0.42) | SLC6A2SLC6A4CYP3A4CYP2D6SLC6A3 | |
| SCHEMBL2557799 | 0.78 | — | — | |
| SCHEMBL8428133 | 0.72 | — | — | |
| SCHEMBL20738704 | 0.72 | — | — | |
| SCHEMBL25308520 | 0.72 | — | — | |
| SCHEMBL5576189 | 0.72 | — | — | |
| SCHEMBL5576184 | 0.72 | — | — | |
| SCHEMBL14928671 | 0.72 | — | — | |
| SCHEMBL5104539 | 0.72 | ALOX5 (0.42) | SLC6A2SLC6A4CYP3A4CYP2D6SLC6A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4245308-A1 | CELL PREPARATION TO BE USED FOR PREVENTING DECREASE IN MUSCLE MASS | Human Life Cord Japan Inc. (JP) | 2023-09-20 | — | — | EP | disclosed |
| WO-2023122580-A2 | POLYPEPTIDES TARGETING CD105 + CANCERS | BAYLOR COLLEGE OF MEDICINE (US) | 2023-06-29 | — | — | WO | disclosed |
| EP-3075846-B1 | CELL CULTURE MEDIUM AND CULTURE METHOD USING THE SAME | KANEKA CORP (JP) | 2020-09-16 | — | — | EP | disclosed |
| US-10377984-B2 | Cell culture medium and culture method using the same | KANEKA CORPORATION (JP) | 2019-08-13 | — | — | US | disclosed |
| US-20180320130-A1 | CELL CULTURE MEDIUM AND CULTURE METHOD USING THE SAME | KANEKA CORPORATION (JP) | 2018-11-08 | — | — | US | disclosed |
| US-20160376549-A1 | CELL CULTURE MEDIUM AND CULTURE METHOD USING THE SAME | KANEKA CORPORATION (JP) | 2016-12-29 | — | — | US | disclosed |
| EP-3075846-A1 | CELL CULTURE MEDIUM AND CULTURE METHOD USING SAME | Kaneka Corporation (JP) | 2016-10-05 | — | — | EP | disclosed |
| EP-2641086-A1 | METHOD FOR SCREENING DRUGS FOR SUPPRESSING INFLAMMASOME ACTIVITY | Kyoto University (JP) | 2013-09-25 | — | — | EP | disclosed |
| WO-2012067265-A1 | METHOD FOR SCREENING DRUGS FOR SUPPRESSING INFLAMMASOME ACTIVITY | KYOTO UNIVERSITY (JP) | 2012-05-24 | — | — | WO | disclosed |
| CN-102439139-A | Cell mass derived from cancer tissue and process for preparing same | REI MEDICAL CO LTD | 2012-05-02 | — | — | CN | disclosed |
| WO-2011132799-A1 | METHOD FOR INDUCING DIFFERENTIATION OF PLURIPOTENT STEM CELLS INTO SKELETAL MUSCLE OR SKELETAL MUSCLE PROGENITOR CELLS | KYOTO UNIVERSITY (JP) | 2011-10-27 | — | — | WO | disclosed |